92011 ⎘
Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings; Monocyclic monocarboxylic acids; Benzoic acid Salts thereof
Psilocin crystalline forms
#2PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF
#3SALTS OF AN ANTIOXIDANT AND CRYSTALLINE FORMS THEREOF
#4COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
#5M-CHOLINE RECEPTOR AGONIST COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#6SALT CRYSTALS
#7Method for manufacturing a light emitting element including a quantum dot composition
#8PHARMACEUTICALLY ACCEPTABLE SALTS OF PSILOCIN AND USES THEREOF
#95-HT3 RECEPTOR MODULATOR, THE CRYSTALLINE FORM, METHODS OF MAKING, AND USE THEREOF
#10NICOTINE SALT WITH META-SALICYLIC ACID AND APPLICATIONS THEREIN
#11Pharmaceutically acceptable salts of psilocin and uses thereof
#12COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS
#13Quantum dot composition including a ligand bonded to a surface of a quantum dot, light emitting element including an emission layer containing a quantum dot and ligand residues, and method for manufacturing the same
#14Co-crystals of sodium benzoate and uses thereof
#15Co-crystals of lithium benzoate and uses thereof
#16Resist composition and patterning process
#17Methods of preparing co-crystals of ibrutinib with carboxylic acids
#18Nicotine salt with meta-salicylic acid and applications therein
#19Co-crystals of lithium benzoate and uses thereof
#20Co-crystals of sodium benzoate and uses thereof
#21Multi-branched cationic phosphonium salt, forward osmosis extract employing the same and forward osmosis seawater desalination process
#22POLYMORPHIC FORMS OF SODIUM BENZOATE AND USES THEREOF
#23Co-crystals and pharmaceutical compositions comprising the same
#24Polymorphic forms of sodium benzoate and uses thereof
#25Co-crystals of ibrutinib with carboxylic acids
#26Nicotine salt with meta-salicylic acid and applications therein
#274-AZIDOBUTYLAMINES AND PROCESSES FOR PREPARING
#28Compositions, methods, and systems for the synthesis and use of imaging agents
#29Resist composition, method of forming resist pattern, compound, and acid diffusion control agent
#30Quaternary ammonium compounds and their use as fuel or lubricant additives
#31Resist composition and patterning process
#32Resist composition, method of forming resist pattern, compound, and acid diffusion control agent
#33Compositions, methods, and systems for the synthesis and use of imaging agents
#34Co-crystals and pharmaceutical compositions comprising the same
#35Zinc or Copper (II) salt and use thereof as a biocide
#36Nicotine salt with meta-salicylic acid
#37Chemically-amplified positive resist composition and resist patterning process using the same
#38Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
#39ACID ADDITION SALTS OF 5ALPHA-HYDROXY-6BETA-[2-(1H-IMIDAZOL-4-YL)ETHYLAMINO]CHOLESTAN-3BETA-OL
#40Compositions, methods, and systems for the synthesis and use of imaging agents
#41Polymomorph of desvenlafaxine benzoate
#42Salt forms of a xanthine compound
#43Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
#44Organic compounds
#45SOLID FORMS OF (±)-O-DESMETHYLVENLAFAXINE SALTS
#46Salt and photoresist composition containing the same
#47Methods for making organozinc salts and compositions containing the same
#48Process for alkaline hydrolysis of carboxylic acid derivatives to carboxylic acids
#49Method for deuteration of an aromatic ring
#50Method of manufacturing a granular mineral composition
#51Method for producing ethers, esters or acid anhydrides
#52Method of making salt
#53Production of ammonium salts of aromatic carboxylic acids
#54Pharmaceutically acceptable salts of psilocin and uses thereof